<DOC>
	<DOCNO>NCT00889070</DOCNO>
	<brief_summary>Assess burden disease associate RSV infection premature child outpatient setting .</brief_summary>
	<brief_title>Respiratory Events Among Premature Infants</brief_title>
	<detailed_description>The primary objective prospective study assess burden disease associate RSV infection , measured/determined rate outpatient medically attended LRI , emergency room visit hospitalization among preterm infant ( 32-≤36 wGA ) RSV season , medical/health consequence , measure wheeze event , infant 's first RSV season , May 2009 .</detailed_description>
	<criteria>Written inform consent parent/guardian participate study Male female preterm infant 32≤36 wGA Infant ≤ 6month old time enrollment Parent/guardian ability willingness follow study protocol ( first RSV season ) require protocol Receipt RSV prophylactic agent : palivizumab , IGIV , motavizumab time prior enrollment Participation trial investigational RSV prophylaxis RSV therapeutic agent Presence BPD CHD ( surgically treat PDA , ASD VSD ) Condition limit life span 6 month less date enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>